MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$8,549,017
Unit: Dollar
Positive Cash Flow Breakdown
Impairment of intangible assets
Accounts payable and accrued lia...
Amortization of right-of-use ass...
Others
Negative Cash Flow Breakdown
Net loss
Lease obligations
Share issuance costs
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-06-30
2025-06-30
Net loss
-12,560,850
-8,162,133
Amortization and depreciation
205,271
212,839
Share-based compensation
106,866
119,307
Amortization of right-of-use assets
503,085
321,885
Loss on disposal of fixed assets
-7,136
-
Interest income received on short-term investments
-
-34
Impairment of fixed assets
189,225
-
Unrealized foreign exchange loss
-
75,928
Impairment of intangible assets
1,457,926
-
Credit losses
-
2,424
Interest income received on short-term investments
1,073
-
Inventories
-
-283,151
Unrealized foreign exchange loss
-7,151
-
Prepaids and other currents assets
-83,038
-173,980
Accounts receivable
-
114,690
Other non-current assets
32,324
-
Accounts payable and accrued liabilities
618,679
-249,728
Lease obligations
-745,529
-429,880
Operating cash flow used by discontinued operations
1,517,886
-
Total cash used in operating activities
-8,643,513
-7,766,951
Proceeds from the private placement
-
8,130,299
Proceeds from the private placement
231,675
5,024,891
Share issuance costs
137,179
883,978
Total cash provided by financing activities
94,496
12,271,212
Increase (decrease) in cash and cash equivalents during the period
-8,549,017
4,504,261
Effect of exchange rate changes on cash
-
0
Cash and cash equivalents beginning of the year
10,743,430
6,571,610
Cash and cash equivalents end of the year
2,194,413
11,075,871
Page 1
Unit: Dollar.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
INM Cash Flow Sankey Diagram
Sankey diagram visualizing INM cash flow for the period
Proceeds from the private
placement
$231,675
(-95.39%↓ Y/Y)
Total cash provided by
financing activities
$94,496
(-99.23%↓ Y/Y)
Canceled cashflow
$137,179
Increase (decrease) in
cash and cash...
-$8,549,017
(-289.80%↓ Y/Y)
Canceled cashflow
$94,496
Operating cash flow used by
discontinued operations
$1,517,886
Impairment of intangible
assets
$1,457,926
Accounts payable and
accrued liabilities
$618,679
(347.74%↑ Y/Y)
Amortization of right-of-use
assets
$503,085
(56.29%↑ Y/Y)
Amortization and
depreciation
$205,271
(-3.56%↓ Y/Y)
Impairment of fixed assets
$189,225
Share-based compensation
$106,866
(-10.43%↓ Y/Y)
Prepaids and other
currents assets
-$83,038
(52.27%↑ Y/Y)
Unrealized foreign
exchange loss
-$7,151
(-109.42%↓ Y/Y)
Loss on disposal of
fixed assets
-$7,136
Share issuance costs
$137,179
(-84.48%↓ Y/Y)
Total cash used in
operating activities
-$8,643,513
(-11.29%↓ Y/Y)
Canceled cashflow
$4,696,263
Net loss
-$12,560,850
(-53.89%↓ Y/Y)
Lease obligations
-$745,529
(-73.43%↓ Y/Y)
Other non-current
assets
$32,324
Interest income received
on short-term...
$1,073
(3255.88%↑ Y/Y)
Buy us a coffee
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)